% | $
Quotes you view appear here for quick access.

Nymox Pharmaceutical Corporation Message Board

  • mghmd mghmd Jan 30, 2014 11:32 AM Flag

    The Positive case for NYMX

    Although there is skepticism toward the company management, particularly its secretive approach to providing information, indicates a conclusion date for both phase 3 trials as April 2014. So it is likely we will have the verdict in 2Q2014.

    A Google search indicates that many urologists involved in the trials( who are not paid consultants for the company) have publicly praised the ease of use and efficacy of NX-1207. The drug only has to do significantly better then the saline placebo in the phase3 studies, which seems highly likely. The independent safety review board has already cleared the drug. Hence, I see a high likelihood of FDA approval. Urology colleagues tell me there is a strong need for a simple, office based procedure for BPH, which afflicts 40% of men over 50. The procedure will almost certainly be a money maker for urologists, and there is a huge reservoir of symptomatic men who are afraid of surgery but would be eager for a simple office procedure, so a rapid ramp-up is very likely. Add on the possibility of an effective Rx for low grade prostate cancer, and I think you have a compelling risk reward scenario.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.22-0.03(-0.92%)Oct 6 3:59 PMEDT